Martina Ott

Director and Head of Department Cell Engineering & Safety @Immatics

Tübingen, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2023 — Present

Director and Head of Department Cell Engineering & Safety @Immatics

View department →

Tübingen, DE

Leading the Department Cell Engineering and Safety, overseeing preclinical efficacy and safety testing of TCR-based modalities, including adoptive cell therapies (ACT) and soluble TCR bispecifics. Driving advanced cell-engineering strategies for innovative autologous and allogeneic T-cell and other off-the-shelf therapies targeting solid tumors.

EDUCATION

2003 — 2008

The Julius Maximilians University of Würzburg

Diploma in Biological Science, Biotechnology, Biochemistry, Cell Biology and Developmental Biology

N/A

DKFZ German Cancer Research Center

Doctor of Philosophy - PhD, Tumor Immunology

ABOUT MARTINA OTT

Specialist in Tumor Immunology, Oncology, Immunotherapies, and Drug Target Discovery and Validation- PhD in Tumor Immunology, with in-depth experience in preclinical development and validation of immunotherapies, immune profiling, handling of clinical samples, generating SOPs and protocols for clinical trials, and performing immune monitoring and clinical trial documentation- Experienced leader of international, multidisciplinary & cross-functional teams

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.